Yong-Chao Yao

From sensitivity challenges to nanozyme-driven signal amplification in lateral flow immunoassays for biomarker detection.

Disease-related molecular markers are central to early diagnosis, treatment evaluation, and prognostic prediction. Conventional laboratory techniques, such as enzyme-linked immunosorbent assays (ELISA), require multiple incubation and washing steps and depend on specialized instrumentation. These requirements limit the...